Please login to the form below

Not currently logged in
Email:
Password:

Revolution Medicines appoints Dr Stephen Kelsey

He joins the firm from Onkaido Therapeutics

Dr Stephen KelseyRevolution Medicines has appointed Dr Stephen Kelsey as its senior leader in a role that will see him focus on advancing medical agendas to aid cancer patients.

Most recently president at Onkaido Therapeutics, Kelsey’s specialty lies within oncology and development.

He said: “Revolution Medicines uses a novel approach to drug discovery that enables it to tackle promising cancer targets that have been difficult to access by convention means.

“I’m impressed with the quality of the company’s research team, founders and advisors, and am keen to help bring the next generation of transformational therapeutics to cancer patients.”

Prior to his time at Onkaido Therapeutics, Kelsey has served in several senior positions at Medivation, Generon and Genentech, where he held the role of vice president, haematology and oncology.

Mark Goldsmith, president and chief executive officer of Revolution Medicines, said: “Steve has had a distinguished career in oncology as both an academic clinician and a drug development executive in the biotechnology industry.

“He is superbly positioned to help us by deliver great benefit to cancer patients by advancing our lead programmes and creating a sustainable product pipeline that harnesses frontier oncology targets.”

31st March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics